Lipolytic Effects of GH in Human Subjects in Vivo

Status Completed

Clinical Trial Summary

Growth hormone (GH) induces fat metabolism. The mechanisms underlying the fat metabolizing effects of GH remain elusive. However, it is known that insulin suppresses fat metabolism, and GH inhibits the expression of certain insulin-dependent signaling proteins. We therefore hypothesize that the fat metabolizing effects of GH depend on abrogation of insulin-dependent signaling pathways.

In order to investigate the fat metabolizing effects of GH, we'll analyze consecutive adipose tissue biopsies taken after GH exposure and GH blocking, respectively.

Knowledge of the effects of growth hormone and fat metabolism can in shot-sight as well as in long-sight have great importance for the understanding of growth disorders from overweight and type 2 diabetes to malnutrition and eating disorders.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02782221
Study type	Interventional
Source	University of Aarhus
Contact
Status	Completed
Phase	N/A
Start date	May 30, 2016
Completion date	January 15, 2017

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT01916603` - Diet, Physical Activity and Breastfeeding Intervention on Maternal Nutrition, Offspring Growth and Development	N/A
Completed	`NCT02402985` - Comparison of a Plant Protein Diet to a Animal Protein Diet Emphasized in Type 2 Diabetics	N/A
Completed	`NCT02380846` - The Metabolic Effects of Consuming Carbohydrate With Different Protein Types	N/A
Completed	`NCT01616082` - Effect of Caloric Restriction on Fat Oxidation in Obese Men and Women (Magellan II)	N/A
Completed	`NCT01737164` - Effect of Age on Glucose and Lipid Metabolism	N/A
Terminated	`NCT00935766` - Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries	Phase 3
Enrolling by invitation	`NCT00628199` - Study to Create Potential Cell-Based Therapies to Treat Human Disease and Disability
Recruiting	`NCT04958109` - Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Oral Glucose Tolerance Test	Phase 1
Completed	`NCT02275429` - Metabolic Disorders in Ultramarathon Runners During and After the Reunion Island Madmen's Diagonal	N/A
Completed	`NCT01968720` - Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia	Phase 2
Completed	`NCT01719913` - The Effect of Gluten on Gut Microbiome and Metabolic Health.	N/A
Completed	`NCT01705782` - The Effects of Amino Acid Supplement During Acute Inflammation.	N/A
Completed	`NCT01708681` - Lean Seafood Intake and Postprandial Metabolism	N/A
Completed	`NCT01435382` - A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia	Phase 1
Recruiting	`NCT02629926` - Transitional Growth Hormone (GH) Use in Growth Hormone Deficient (GHD) Cancer Survivors	Phase 4
Completed	`NCT00707746` - Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant Subjects	Phase 2
Completed	`NCT00550706` - Drug Utilization Prevalence in a Pediatric Care Medical Center	N/A
Completed	`NCT03941392` - Nutritional Study in Spanish Pediatric Population
Terminated	`NCT02440945` - Use of the DBS for the Follow-up of Blood Clinical Parameters of Old People	N/A
Not yet recruiting	`NCT06000605` - Brain Substrate Switch to Ketones and Lactate	N/A